Literature DB >> 23633669

Modern diagnosis of Trichomonas vaginalis infection.

Marcia M Hobbs1, Arlene C Seña.   

Abstract

Recent advances in tests for the sexually transmitted protozoan parasite Trichomonas vaginalis have increased opportunities for diagnosis and treatment of this important sexually transmitted infection. This review summarises currently available tests, highlighting their performance characteristics, advantages and limitations. The recent development of molecular tests for the detection of T vaginalis, including rapid antigen detection and nucleic acid amplification tests, has significantly improved the quality of diagnostics for trichomoniasis, particularly in women. In light of the expanded menu of testing options now available, improved recognition and better control of trichomoniasis are in sight, which should enable the eventual reduction of adverse reproductive consequences associated with T vaginalis infection.

Entities:  

Keywords:  DIAGNOSIS; LABORATORY METHODS; MOLECULAR TECHNIQUES; TESTING; TRICHOMONAS

Mesh:

Year:  2013        PMID: 23633669      PMCID: PMC3787709          DOI: 10.1136/sextrans-2013-051057

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  29 in total

1.  Consider diagnosis and treatment of trichomoniasis in men.

Authors:  J N Krieger
Journal:  Sex Transm Dis       Date:  2000-04       Impact factor: 2.830

2.  Comparison of latex agglutination, wet preparation, and culture for the detection of Trichomonas vaginalis.

Authors:  Y Adu-Sarkodie; B K Opoku; K A Danso; H A Weiss; D Mabey
Journal:  Sex Transm Infect       Date:  2004-06       Impact factor: 3.519

3.  Performance of rapid immunochromatographic assay in the diagnosis of Trichomoniasis vaginalis.

Authors:  Mamdouh M Hegazy; Nora L El-Tantawy; Mohamed M Soliman; Ehaab S El-Sadeek; Hassan S El-Nagar
Journal:  Diagn Microbiol Infect Dis       Date:  2012-06-21       Impact factor: 2.803

4.  Methods for detection of Trichomonas vaginalis in the male partners of infected women: implications for control of trichomoniasis.

Authors:  Marcia M Hobbs; Dana M Lapple; Lisa F Lawing; Jane R Schwebke; Myron S Cohen; Heidi Swygard; Julius Atashili; Peter A Leone; William C Miller; Arlene C Seña
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

5.  Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial.

Authors:  Jane R Schwebke; Marcia M Hobbs; Stephanie N Taylor; Arlene C Sena; Michael G Catania; Barbara S Weinbaum; Ann D Johnson; Damon K Getman; Charlotte A Gaydos
Journal:  J Clin Microbiol       Date:  2011-09-21       Impact factor: 5.948

6.  Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.

Authors:  Barbara Van Der Pol; James A Williams; Donald P Orr; Byron E Batteiger; J Dennis Fortenberry
Journal:  J Infect Dis       Date:  2005-11-08       Impact factor: 5.226

Review 7.  APTIMA® Trichomonas vaginalis, a transcription-mediated amplification assay for detection of Trichomonas vaginalis in urogenital specimens.

Authors:  Kimberle Chapin; Sarah Andrea
Journal:  Expert Rev Mol Diagn       Date:  2011-09       Impact factor: 5.225

8.  Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition.

Authors:  R Scott McClelland; Laura Sangare; Wisal M Hassan; Ludo Lavreys; Kishorchandra Mandaliya; James Kiarie; Jeckoniah Ndinya-Achola; Walter Jaoko; Jared M Baeten
Journal:  J Infect Dis       Date:  2007-01-22       Impact factor: 5.226

9.  Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care.

Authors:  Evelyn Byrd Quinlivan; Shilpa N Patel; Catherine A Grodensky; Carol E Golin; Hsiao-Chuan Tien; Marcia M Hobbs
Journal:  Sex Transm Dis       Date:  2012-09       Impact factor: 2.830

10.  High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management.

Authors:  Jane R Schwebke; Edward W Hook
Journal:  J Infect Dis       Date:  2003-07-10       Impact factor: 5.226

View more
  35 in total

Review 1.  [Modern diagnosis of sexually transmitted diseases].

Authors:  N H Brockmeyer; T Meyer
Journal:  Hautarzt       Date:  2016-01       Impact factor: 0.751

2.  Trichomonas vaginalis Virus Among Women With Trichomoniasis and Associations With Demographics, Clinical Outcomes, and Metronidazole Resistance.

Authors:  Keonte J Graves; Arindam P Ghosh; Norine Schmidt; Peter Augostini; W Evan Secor; Jane R Schwebke; David H Martin; Patricia J Kissinger; Christina A Muzny
Journal:  Clin Infect Dis       Date:  2019-11-27       Impact factor: 9.079

Review 3.  Single-Dose Compared With Multidose Metronidazole for the Treatment of Trichomoniasis in Women: A Meta-Analysis.

Authors:  Katharine Howe; Patricia J Kissinger
Journal:  Sex Transm Dis       Date:  2017-01       Impact factor: 2.830

4.  Why Does Trichomonas vaginalis Continue to be a "Neglected" Sexually Transmitted Infection?

Authors:  Christina A Muzny
Journal:  Clin Infect Dis       Date:  2018-07-02       Impact factor: 9.079

Review 5.  Point of care diagnostics for sexually transmitted infections: perspectives and advances.

Authors:  Charlotte Gaydos; Justin Hardick
Journal:  Expert Rev Anti Infect Ther       Date:  2014-02-03       Impact factor: 5.091

Review 6.  Laboratory Diagnosis of Sexually Transmitted Infections in Cases of Suspected Child Sexual Abuse.

Authors:  Xuan Qin; Ann J Melvin
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

7.  Impact of specimen storage temperature and time on the implementation of GeneXpert® testing for sexually transmitted infections in resource-constraint settings.

Authors:  Liteboho D Maduna; Marleen M Kock; Andrew Medina-Marino; Jeffrey D Klausner; Remco P H Peters
Journal:  J Microbiol Methods       Date:  2019-09-10       Impact factor: 2.363

Review 8.  Rapid and point-of-care tests for the diagnosis of Trichomonas vaginalis in women and men.

Authors:  Charlotte A Gaydos; Jeffrey D Klausner; Nitika Pant Pai; Helen Kelly; Cordelia Coltart; Rosanna W Peeling
Journal:  Sex Transm Infect       Date:  2017-07-06       Impact factor: 3.519

9.  Integrated morphologic and molecular analysis of Trichomonas vaginalis, Mycoplasma hominis, and human papillomavirus using cytologic smear preparations.

Authors:  I Nikas; A Hapfelmeier; M Mollenhauer; D Angermeier; M Bettstetter; R Götz; M Schmidmayr; V Seifert-Klauss; A Muckenhuber; U Schenck; Gregor Weirich
Journal:  Parasitol Res       Date:  2018-03-17       Impact factor: 2.289

10.  Accuracy of the BD MAX™ vaginal panel in the diagnosis of infectious vaginitis.

Authors:  Amaia Aguirre-Quiñonero; I Sáez de Castillo-Sedano; F Calvo-Muro; A Canut-Blasco
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-01-26       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.